ClearNote Health has launched an enhanced pancreatic cancer test, reporting 82.6% sensitivity and 97.5% specificity in high-risk patients using a multianalyte, multiomic blood-based approach.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
The G4X system can analyze 128 samples per run with 500-plex RNA and 18-plex protein capabilities, targeting translational research and clinical applications.
The automation-compatible system works with plasma, serum, urine and cerebrospinal fluid samples from 1 ml to 4 ml input volumes.
Researchers have identified blood biomarkers that may enable detection of Parkinson’s disease up to 20 years before symptoms.
